Position in AZN
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$75,848
-$3,040 QoQ
Shares Held
400
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#1,265
of 1,459 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026DHJJ Financial Advisors, Ltd. holds $2,259,093 across 11 Drug Manufacturers - General names. AZN ranks #6 (3.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
4,522 | $581,077 | |
| 2 | JNJ |
Johnson & Johnson
|
2,058 | $522,670 | |
| 3 | LLY |
ELI LILLY & Co
|
348 | $417,401 | |
| 4 | ABBV |
AbbVie Inc.
|
1,638 | $412,186 | |
| 5 | AMGN |
Amgen Inc
|
319 | $115,516 | |
| 6 | AZN |
Astrazeneca PLC
This page
|
400 | $75,848 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
825 | $47,536 | |
| 8 | PFE |
Pfizer Inc
|
1,744 | $41,995 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $75,848 | 400 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $78,888 | 400 | Shares | Sole | 2026-04-09 | |
| No filing history on record for this holder in this stock. | ||||||